• Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

U.S. Loses Key Case on Rights to H.I.V.-Prevention Drugs

In an unusual court trial, a federal jury sided with the drug maker Gilead Sciences in a dispute over who came up with the idea of using a daily pill to prevent H.I.V.

Rebecca Robbins
Author: Rebecca Robbins

Written by

Rebecca Robbins

in

Centers for Disease Control and Prevention, Compensation for Damages (Law), Decisions and Verdicts, Drugs (Pharmaceuticals), Gilead Sciences Inc, Health and Human Services Department, Inventions and Patents, Suits and Litigation (Civil)
←Fox Producer Dismisses, for Now, Case Accusing Network of Coercion
How Wall Street Is Preparing for a Debt Ceiling Showdown→

More posts

  • Iran says no meeting planned with US; indicates indirect talks through Pakistan

  • Teddy Swims Says Coachella Sun Badly Burned Him, Going Back for Stagecoach

  • ‘Killing in prison is not difficult’ – the rise in cold-blooded attacks behind bars

  • Mariah Carey Scoffs at Estranged Bro’s Claims in Bitter Court Battle

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube